The Genotype CDiff test permits the detection and differentiation of non-pathogenic, virulent and hypervirulent strains of C difficile directly from stool and rectal swabs, or from culture.
Clostridium difficile (C difficile) is a gram-positive, anaerobic, spore-forming intestinal bacteria found in approximately three per cent of adults and 66 per cent of infants.
The Hain Lifescience Genotype CDiff offers hospitals a same-day platform that can differentiate between non-pathogenic, virulent and hypervirulent (including ribotype 027) strains.
As well as having inbuilt controls, the assay also has markers for: C difficile - generic marker that bacteria is present; toxins A and B - identification of pathogenic strains; binary toxin - associated with severe clinical courses; three characteristic deletions in the toxin-regulator gene - indication of hyper-production of toxins; and resistance to moxifloxacin - used to identify and differentiate virulent and hyper-virulent strains
